Compare FTH & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTH | OPFI |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | 29 | 410 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.0M | 802.7M |
| IPO Year | 2021 | N/A |
| Metric | FTH | OPFI |
|---|---|---|
| Price | $24.48 | $9.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 306.9K | ★ 445.4K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $97.52 |
| Revenue Next Year | N/A | $10.95 |
| P/E Ratio | ★ N/A | $67.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.50 | $7.36 |
| 52 Week High | $37.90 | $12.45 |
| Indicator | FTH | OPFI |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 57.82 |
| Support Level | $23.82 | $9.72 |
| Resistance Level | $31.61 | $10.21 |
| Average True Range (ATR) | 2.65 | 0.30 |
| MACD | -0.69 | 0.03 |
| Stochastic Oscillator | 16.06 | 69.06 |
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
OppFi Inc. is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to expand credit access for everyday Americans. It recognizes revenue from finance charges on installment and SalaryTap contracts using the interest method.